Literature DB >> 25916280

Paroxysmal atrial fibrillation in young cryptogenic ischemic stroke: A 3-week ECG Holter monitoring study.

Daniel Sanak1, Martin Hutyra2, Michal Kral1, Andrea Bartkova1, Jana Zapletalova3, Marian Fedorco2, Tomas Veverka1, David Vindis2, Tomas Dornak1, Tomas Skala2, David Skoloudik4, Milos Taborsky2, Petr Kanovsky1.   

Abstract

BACKGROUND: Atrial fibrillation is known very frequent cause of ischemic stroke. Undetected paroxysmal atrial fibrillation (PAF) is thus often considered a possible cause of cryptogenic ischemic stroke (CIS). The aim of this prospective study was to detect PAF using ECG Holter monitoring and determinate whether prolongation of the Holter monitoring to 3 weeks would increase the detection rates of PAF in young CIS patients ≤ 50 years.
METHODS: The study set consisted of IS patients ≤ 50 years enrolled in the HISTORY (Heart and Ischemic STrOke Relationship studY) study (NCT01541163). CIS was defined according to the TOAST criteria including the absence of ultrasonographic or angiographic signs of atherosclerosis, vasculitis or dissection. Admission ECG, serum levels of high sensitive Troponin T (hs TnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP), markers of thrombophilia, transoesophageal echocardiography (TEE) and 24-hour ECG-Holter monitoring were performed in all patients. In case of negative 24-h ECG Holter, an additional 3-weeks monitoring was done.
RESULTS: Of the 105 enrolled patients ≤ 50 years, 95 (90%) were identified as cryptogenic (49 males, mean age 39.1 ± 8.2 years). All CIS patients had normal admission ECG. In total, PAF was detected in 9 (9.5%, 95% CI: 3.5% - 17.8%) patients; in two during 24-h ECG Holter and in seven during 3-weeks Holter monitoring. Patients with PAF had more frequently elevated admission hs TnT and NT-proBNP levels (P - 0.0001).
CONCLUSIONS: PAF was detected in 9.5% of young CIS patients and 3-weeks ECG Holter monitoring increased the detection rate.

Entities:  

Keywords:  ECG Holter monitoring; cryptogenic ischemic stroke; paroxysmal atrial fibrillation; young stroke

Mesh:

Year:  2015        PMID: 25916280     DOI: 10.5507/bp.2015.019

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  5 in total

1.  European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.

Authors:  Marta Rubiera; Ana Aires; Kateryna Antonenko; Sabrina Lémeret; Christian H Nolte; Jukka Putaala; Renate B Schnabel; Anil M Tuladhar; David J Werring; Dena Zeraatkar; Maurizio Paciaroni
Journal:  Eur Stroke J       Date:  2022-06-03

Review 2.  High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.

Authors:  Cian P McCarthy; Omair Yousuf; Alvaro Alonso; Elizabeth Selvin; Hugh Calkins; John W McEvoy
Journal:  Am J Cardiol       Date:  2017-02-09       Impact factor: 2.778

3.  Epicardial Fat Thickness and Free Fatty Acid Level are Predictors of Acute Ischemic Stroke with Atrial Fibrillation.

Authors:  Kyoung-Im Cho; Bong-Joon Kim; Sang-Hoon Cho; Jin-Hyung Lee; Meyung-Kug Kim; Bong-Goo Yoo
Journal:  J Cardiovasc Imaging       Date:  2018-06-12

4.  Diagnostic performance of a wearing dynamic ECG recorder for atrial fibrillation screening: the HUAMI heart study.

Authors:  Wenxia Fu; Ruogu Li
Journal:  BMC Cardiovasc Disord       Date:  2021-11-20       Impact factor: 2.298

5.  Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies.

Authors:  Kejia Zhang; Joseph Kamtchum-Tatuene; Mingxi Li; Glen C Jickling
Journal:  Stroke Vasc Neurol       Date:  2020-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.